Related Experiment Video
Updated: Aug 9, 2026
13:08
Expansion of Human Peripheral Blood γδ T Cells using Zoledronate
Published on: September 9, 2011
H2 receptor antagonists and human granulopoiesis
Experientia
|March 15, 1985
Summary
Two H2 receptor antagonists, ranitidine and cimetidine, showed similar toxicity to human granulomonopoietic precursors (CFU-GM) in vitro. This finding is significant despite ranitidine
Area of Science:
- Pharmacology
- Hematology
- Cell Biology
Background:
- H2 receptor antagonists are widely used for acid-related gastrointestinal disorders.
- The potential impact of these drugs on hematopoietic stem cells requires investigation.
- Granulomonopoietic precursors (CFU-GM) are crucial for innate immunity.
Purpose of the Study:
- To investigate the in vitro effects of ranitidine and cimetidine on human granulomonopoietic precursor growth.
- To compare the toxicity profiles of these two H2 receptor antagonists on CFU-GM.
Main Methods:
- In vitro culture of human bone marrow cells.
- Exposure of cultures to varying concentrations of ranitidine and cimetidine.
- Assessment of colony formation by granulomonopoietic precursors (CFU-GM).
Main Results:
- Both ranitidine and cimetidine exhibited toxicity towards human CFU-GM in a dose-dependent manner.
- Ranitidine demonstrated comparable toxicity to cimetidine, despite its significantly higher H2 receptor antagonist activity.
- The anti-H2 receptor activity did not correlate with the observed toxicity on CFU-GM.
Conclusions:
- Ranitidine and cimetidine possess similar in vitro toxicity to human granulomonopoietic precursors.
- The H2 receptor antagonist potency does not predict CFU-GM toxicity.
- Further studies are warranted to assess the clinical relevance of these findings in patients receiving these medications.
More Related Videos
Related Concept Videos
01:15Differentiation of Common Myeloid Progenitor Cells
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
01:01Regulation of Hematopoietic Stem Cells
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
01:28Role of Hematopoietic Growth Factors
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
01:28Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
01:27Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...